4 medicines held by Bracco International B.V. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| ProHance, 279.3 mg/ml, Solution for Injection, 10 ml vial PA0788/001/002 |
Gadoteridol | Bracco International B.V. | Marketed |
| ProHance, 279.3 mg/ml, Solution for Injection, 15 ml vial PA0788/001/003 |
Gadoteridol | Bracco International B.V. | Not marketed |
| ProHance, 279.3 mg/ml, solution for injection, 20 ml vial PA0788/001/004 |
Gadoteridol | Bracco International B.V. | Marketed |
| SonoVue 8 microlitres/mL powder and solvent for dispersion for injection EU/1/01/177/002 |
Sulphur hexafluoride | Bracco International B.V. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.